Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Cost of Revenue: 2011-2024

Historic Cost of Revenue for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $60.1 million.

  • Mimedx Group's Cost of Revenue rose 22.17% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.9 million, marking a year-over-year increase of 24.31%. This contributed to the annual value of $60.1 million for FY2024, which is 9.96% up from last year.
  • Mimedx Group's Cost of Revenue amounted to $60.1 million in FY2024, which was up 9.96% from $54.6 million recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Cost of Revenue peaked at $60.1 million during FY2024, and registered a low of $39.3 million during FY2020.
  • In the last 3 years, Mimedx Group's Cost of Revenue had a median value of $54.6 million in 2023 and averaged $54.3 million.
  • Per our database at Business Quant, Mimedx Group's Cost of Revenue dropped by 8.71% in 2020 and then grew by 21.92% in 2022.
  • Mimedx Group's Cost of Revenue (Yearly) stood at $39.3 million in 2020, then grew by 0.76% to $39.6 million in 2021, then grew by 21.92% to $48.3 million in 2022, then increased by 13.08% to $54.6 million in 2023, then rose by 9.96% to $60.1 million in 2024.